Home » Authors » Kim Coghill

Articles by Kim Coghill

CoTherix Files Ventavis NDA In Pulmonary Arterial Hypertension

July 2, 2004

By Kim Coghill

No Comments

CoTherix Files Ventavis NDA In Pulmonary Arterial Hypertension

July 2, 2004

By Kim Coghill

No Comments

Cellegy Resubmits NDA For Cellegesic In Anal Fissures

July 1, 2004

By Kim Coghill

No Comments

Amylin, Lilly File For Approval Of Exenatide In Type II Diabetes

July 1, 2004

By Kim Coghill

No Comments

Amylin Pharmaceuticals Inc. and partner Eli Lilly and Co. filed a new drug application seeking approval of exenatide as a treatment for Type II diabetes. (BioWorld Today)

Amylin, Lilly File For Approval Of Exenatide In Type II Diabetes

July 1, 2004

By Kim Coghill

No Comments

Amylin Pharmaceuticals Inc. and partner Eli Lilly and Co. filed a new drug application seeking approval of exenatide as a treatment for Type II diabetes. (BioWorld Today)

Cellegy Resubmits NDA For Cellegesic In Anal Fissures

July 1, 2004

By Kim Coghill

No Comments

Decisions Regarding Follow-On Biologics To Be Made In Public

June 30, 2004

By Kim Coghill

No Comments

Decisions Regarding Follow-On Biologics To Be Made In Public

June 30, 2004

By Kim Coghill

No Comments

LSBC, University Of Louisville Join Up To Develop HPV Drugs

June 29, 2004

By Kim Coghill

No Comments

LSBC, University Of Louisville Join Up To Develop HPV Drugs

June 29, 2004

By Kim Coghill

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Articles by Kim Coghill

CoTherix Files Ventavis NDA In Pulmonary Arterial Hypertension

CoTherix Files Ventavis NDA In Pulmonary Arterial Hypertension

Cellegy Resubmits NDA For Cellegesic In Anal Fissures

Amylin, Lilly File For Approval Of Exenatide In Type II Diabetes

Amylin, Lilly File For Approval Of Exenatide In Type II Diabetes

Cellegy Resubmits NDA For Cellegesic In Anal Fissures

Decisions Regarding Follow-On Biologics To Be Made In Public

Decisions Regarding Follow-On Biologics To Be Made In Public

LSBC, University Of Louisville Join Up To Develop HPV Drugs

LSBC, University Of Louisville Join Up To Develop HPV Drugs

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

‘Evo’ AI can design complete genomes